AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

14 recruiting trials

for Refractory Immune Cytopenia

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia NCT06826430Phase 11 site๐Ÿ“ Beijing Juventas Cell Therapy Ltd. ยท Tests: Inaticabtagene autoleucel Injection BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases NCT06787989Phase 11 site๐Ÿ“ Chengdu iCell Gene Therapeutics ยท Tests: BCMA-CD19 cCAR T cells Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis NCT04800458NA1 site๐Ÿ“ Pessac University Hospital, Bordeaux ยท Tests: Blood samples The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia NCT05599880Phase 24 sites๐Ÿ“ Guri-si๐Ÿ“ Seoul๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Bortezomib Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site๐Ÿ“ Tianjin CytoCares Inc ยท Tests: CC312 A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia NCT07175493Phase 1, Phase 23 sites๐Ÿ“ Zhengzhou๐Ÿ“ Changzhi๐Ÿ“ Tianjin Keymed Biosciences Co.Ltd ยท Tests: CM336 Injection RN1201 Injection in the Treatment of Antibody-Mediated Diseases NCT07072247Phase 11 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: CD19 and BCMA-targeted allogeneic CAR-T cells Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease NCT07549698Phase 1, Phase 212 sites๐Ÿ“ Boston๐Ÿ“ Rochester๐Ÿ“ Omaha CRISPR Therapeutics AG ยท Tests: CTX112 Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP) NCT06519565EARLY Phase 12 sites๐Ÿ“ Wuhan๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: PRG-1801 Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia NCT06973356NA1 site๐Ÿ“ Changsha Anhui Provincial Hospital ยท Tests: Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis. Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) NCT06352281Phase 1, Phase 21 site๐Ÿ“ Kunming 920th Hospital of Joint Logistics Support Force of People'sโ€ฆ ยท Tests: CAR-T cells Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia NCT03418038Phase 24 sites๐Ÿ“ Mankato๐Ÿ“ Rochester๐Ÿ“ Eau Claire Mayo Clinic ยท Tests: Ascorbic Acid, Carboplatin, Cisplatin, Cytarabine, Dexamethasone
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy